TCM
WST icon

Tekla Capital Management’s West Pharmaceutical WST Stock Holding History

Tekla Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$5.75M Hold
15,036
– – 0.23% 82
2023
Q1 		$5.21M Buy
+15,036
New +$4.39M 0.2% 79
2021
Q4 		– Sell
-6,240
Closed -$2.65M – 182
2021
Q3 		$2.65M Buy
+6,240
New +$2.63M 0.09% 127

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Tekla Capital Management's WST Position: Q2 2023 in Review

Tekla Capital Management held its West Pharmaceutical (WST) position steady in Q2 2023 at 15,036 shares worth $5.75M. The position accounts for 0.23% of the portfolio, ranked #82.

Tekla Capital Management first reported a position in WST in Q3 2021 and has held it in 3 quarters since. 735 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • Tekla Capital Management held 15,036 shares of West Pharmaceutical worth $5.75M as of Q2 2023.
  • Tekla Capital Management left its West Pharmaceutical share count unchanged in Q2 2023.
  • West Pharmaceutical made up 0.23% of Tekla Capital Management's portfolio in Q2 2023, its #82 holding.
  • Tekla Capital Management first reported a position in West Pharmaceutical in Q3 2021 and has held it in 3 quarters since.
  • 735 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.